Mankind Pharma Limited
MANKIND.NS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$978.27B
Close$
$884.70
Infinity% upside
Current Fair Value
Infinity% upsideUndervalued by Infinity% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $978.27 Billion |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $46.35 |
| Beta | 0.45 |
| Outstanding Shares | 412,834,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 47.86 |
|---|---|
| PEG | 161.69 |
| Price to Sales | 0.0 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
October 26, 2026
EPS Estimate
$15.22
Consensus analyst estimateRevenue Estimate
$41.63 B
Consensus analyst estimateNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$15.65
Consensus analyst estimateRevenue Estimate
$41.81 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Mankind Pharma Limited
20,451 employees
CEO: Sheetal Arora
Headquartered in New Delhi, India, Mankind Pharma Limited is a prominent developer, manufacturer, and marketer of pharmaceutical formulations and consumer healthcare products. The company's primary focus is on the Indian market, though i...